Psoriasis accounts for 17.5% share of global Immunology clinical trial activity in 2020
Psoriasis accounted for a 17.5% share of the global clinical trials within the Immunology therapy area in 2020, registering an…
Clinical Trials Analysis
Latest in
Clinical Trials Analysis
Global clinical trials activity increases 5.9% in Q2 2021 over 4Q average
The global clinical trials activity saw an increase of 5.9% in Q2 2021, when compared with the rolling average of…
Global clinical trials activity increases 10.1% YoY in Q2 2021
Global clinical trials activity increased by 10.1% in Q2 2021, when compared with the same quarter in 2020, according to…
By
‘Novavax refugees’ highlight unfair bureaucracy in trial regulation
Participants in the Novavax Phase III Covid-19 vaccine trials are being left at a disadvantage, with no proof of Covid-19…
ByNon-Alcoholic Steatohepatitis (NASH) accounts for 6.3% share of global Gastrointestinal clinical trial activity in 2020
Non-Alcoholic Steatohepatitis (NASH) accounted for a 6.3% share of the global clinical trials within the Gastrointestinal therapy area in 2020,…
ByStroke accounts for 12.6% share of global Cardiovascular clinical trial activity in 2020
Stroke accounted for a 12.6% share of the global clinical trials within the Cardiovascular therapy area in 2020, registering an…
Rheumatoid Arthritis accounts for 18.9% share of global Immunology clinical trial activity in 2020
Rheumatoid Arthritis accounted for an 18.9% share of the global clinical trials within the Immunology therapy area in 2020, registering…
Osteoarthritis accounts for 26.2% share of global Musculoskeletal Disorders clinical trial activity in 2020
Osteoarthritis accounted for a 26.2% share of the global clinical trials within the Musculoskeletal Disorders therapy area in 2020, registering…